Global Fund to Fight AIDS, TB, & Malaria

$1.3 billion*

Minimum Requirement for American Leadership

The Global Fund is a 21st century public-private partnership designed to accelerate the end of AIDS, tuberculosis (TB) and malaria as epidemics.

Download PDF

Justification for Funding

  • U.S. leadership through the Global Fund and bilateral programs have supported incredible progress in the fight against the three most deadly infectious diseases. To date, the Global Fund partnership has:

Cost of Cuts Below $1.3 Billion

President and Congress Budget Comparison

       Congressional Budget   

       President's Budget Request (Base + OCO)

  • The Administration’s proposed cut of $425 million would translate to:
    • 565,250 fewer lives saved through Global Fund-supported programs
    • Loss of potential to prevent 8 million new HIV, TB and malaria infections
  • The Administration’s proposal to cut the Global Fund is based on a currency fluctuation issue which can be addressed by including on a one-time basis, appropriations or authorizing language that clarifies the 33% U.S. legislative cap on contributions, to address the highly unusual currency swings leading up to the September 2016 Replenishment.
  • If other donor-countries see the U.S. back away from our historic leadership role at the Global Fund then others are likely to follow, and we will have missed a historic opportunity to end the epidemics of HIV, TB, and malaria.


$1.3 billion

Opportunity to Catalyze American Leadership


Justification for Full Funding

  • The Global Fund is a 21st century public-private partnership designed to accelerate the end of AIDS, tuberculosis (TB), and malaria as epidemics. Since 2002, the Global Fund partnership has saved more than 22 million lives and has maintained U.S. bipartisan support for its highly efficient and collaborative work with U.S. bilateral programs, its ability to leverage domestic and donor investment in global health, protect U.S. health security, and spur economic growth. 
  • Even with remarkable progress, AIDS, TB, and malaria still claim more than 2.5 million lives annually, over half a million of which are children. With scientific and service delivery advances, ending these epidemics could and should be a signature 21st century accomplishment.

Impact of Full Funding

Growing drug-resistance and a population under 15 in Africa projected to double by 2050 threaten a resurgence of the 3 diseases absent U.S. leadership.

  • Every $100 million invested in Global Fund-supported programs:
    • Saves 133,000 lives
    • Averts 1.9 million new HIV, tuberculosis, and malaria infections
    • Provides antiretroviral therapy for 107,000 people
    • Provides treatment for 31,000 women to prevent passing HIV to their babies
    • Provides TB treatment and care for 153,000 people
    • Provides 4,300 people with treatment for multidrug-resistant TB
    • Distributes 6.2 million mosquito nets to protect children and families from malaria
    • Provides indoor residual spraying for 1.2 million households to protect children and families
    • Spurs implementing countries own domestic investment of $300 million toward the three diseases
    • Creates $2.2 billion in long-term economic gains

*Enacted FY18 Omnibus Appropriation

For more information, please contact: Soshana Hashmie,

Choose to Invest:   2018  |  2017  |  2016  |  2015  |  2014  |  2013  |  2012